New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease
- PMID: 10608731
- DOI: 10.1046/j.1526-0968.1999.00207.x
New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease
Abstract
Leukocytapheresis (LCAP) is widely used for the treatment of immunological diseases. We studied a new treatment of LCAP using a nonwoven polyester fiber filter. In a basic study, 30-70% of leukocytes were removed. Also, 30-68% of the leukocyte subsets were removed. Sixteen inflammatory bowel disease (IBD) patients, mainly with ulcerative colitis (UC), were treated by this method. Their cytokine activity was normalized in the filter and in the peripheral blood. Eleven of 12 patients with UC were induced to remission. Four patients with Crohn's disease (CD) exhibited improvement. The LCAP using a nonwoven polyester fiber filter was very efficient for treating the patients with IBD. Also, it will be a very useful treatment for immunological diseases and extracorporeal immunomodulation.
Similar articles
-
Basic clinical study of an easy and effective leukocytapheresis by the use of nonwoven polyester filter.Ther Apher. 1998 Nov;2(4):292-6. doi: 10.1111/j.1744-9987.1998.tb00125.x. Ther Apher. 1998. PMID: 10227758
-
Successful treatment of ulcerative colitis with leukocytapheresis using non-woven polyester filter.Ther Apher Dial. 2003 Dec;7(6):536-9. doi: 10.1046/j.1526-0968.2003.00096.x. Ther Apher Dial. 2003. PMID: 15018240
-
Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease.J Gastroenterol. 1995 Jun;30(3):322-9. doi: 10.1007/BF02347507. J Gastroenterol. 1995. PMID: 7647899 Clinical Trial.
-
Leukocytapheresis using a leukocyte removal filter.Ther Apher. 2002 Aug;6(4):261-6. doi: 10.1046/j.1526-0968.2002.00419.x. Ther Apher. 2002. PMID: 12164794 Review.
-
Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease.Curr Pharm Des. 2009;15(18):2110-9. doi: 10.2174/138161209788489104. Curr Pharm Des. 2009. PMID: 19519448 Review.
Cited by
-
Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study.World J Gastroenterol. 2006 Apr 14;12(14):2201-4. doi: 10.3748/wjg.v12.i14.2201. World J Gastroenterol. 2006. PMID: 16610021 Free PMC article.
-
Leukocytapheresis: An "Out-of-Body" Experience in Inflammatory Bowel Disease.Gastroenterol Hepatol (N Y). 2006 Dec;2(12):906-913. Gastroenterol Hepatol (N Y). 2006. PMID: 28331481 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources